# Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

> **NCT04722692** · PHASE3 · RECRUITING · sponsor: **Uppsala University** · enrollment: 500 (estimated)

## Conditions studied

- DCIS
- Breast Cancer
- Breast Neoplasms
- Sentinel Lymph Node

## Interventions

- **DIAGNOSTIC_TEST:** Delayed SLND
- **DIAGNOSTIC_TEST:** Late SLND

## Key facts

- **NCT ID:** NCT04722692
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722692, "Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04722692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
